We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation (RAPID GENE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01184300
Recruitment Status : Completed
First Posted : August 18, 2010
Last Update Posted : November 11, 2011
Spartan Bioscience Inc.
Information provided by (Responsible Party):
Ottawa Heart Institute Research Corporation